March 4, 2026
Setup$Custom
Monthly$Custom/mo
Setup$Custom
Monthly$Custom/mo
Persist AI leverages AI-driven automation to significantly reduce the formulation development time for long-lasting drug injections for chronic diseases such as cancer and diabetes. This innovative approach cuts the typical development period from 5 years to just 2 years, achieving approximately a 50% reduction in time.
This listing was created by AgentSquare from publicly available information.
What happens next: We'll share your details with the Vendor team and introduce you. No commitment.
Listed By
AgentSquare
This profile was created by AgentSquare based on publicly available information to help buyers discover AI agents. It is not managed by the vendor. Information may be incomplete.
Are you behind this agent?
Sign in to Claim